Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vanopdenbosch

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Israel Medical Association Journal : IMAJ|December 4, 2001
Hieronymus Bosch (1450-1516): paleopathology of the medieval disabled and its relation to the Bone and Joint Decade 2000-2010J Dequeker, G Fabry, L Vanopdenbosch
Tijdschrift Voor Psychiatrie|January 8, 2020
[Neurosyphilis: a historical disease with current relevance]K van Hoe, H Van den Ameele, L Vanopdenbosch
Tijdschrift Voor Psychiatrie|July 12, 2023
[Catatonia as an initial presentation of acute disseminated encephalomyelitis]I Lesage, L Vanopdenbosch, M Cambron, et al.
The Journal of Laryngology and Otology|February 14, 2007
Post-traumatic pulsatile tinnitus: the hallmark of a direct carotico-cavernous fistulaB Lerut, C De Vuyst, J Ghekiere, et al.
Journal of Neurology|September 19, 2000
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosisL Vanopdenbosch, B Dubois, M B D'Hooghe, et al.
Acta Neurologica Belgica|November 25, 2024
Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with chronic lymphocytic leukemia (CLL) treated with Acalabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor: a case reportL Janssens, S Huybrecht, S De Blauwe, et al.
Acta Neurologica Belgica|December 1, 2017
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensusBen Sprangers, D Decoo, D Dive, et al.
Acta Neurologica Belgica|April 10, 2017
Corticosteroids in the management of acute multiple sclerosis exacerbationsI Smets, L Van Deun, C Bohyn, et al.
Multiple Sclerosis and Related Disorders|October 11, 2020
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosisH-P Hartung, T Berger, R A Bermel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2019
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter studyC E Leurs, Ham Twaalfhoven, B I Lissenberg-Witte, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Israel Medical Association Journal : IMAJ|December 4, 2001
Hieronymus Bosch (1450-1516): paleopathology of the medieval disabled and its relation to the Bone and Joint Decade 2000-2010J Dequeker, G Fabry, L Vanopdenbosch
Tijdschrift Voor Psychiatrie|January 8, 2020
[Neurosyphilis: a historical disease with current relevance]K van Hoe, H Van den Ameele, L Vanopdenbosch
Tijdschrift Voor Psychiatrie|July 12, 2023
[Catatonia as an initial presentation of acute disseminated encephalomyelitis]I Lesage, L Vanopdenbosch, M Cambron, et al.
The Journal of Laryngology and Otology|February 14, 2007
Post-traumatic pulsatile tinnitus: the hallmark of a direct carotico-cavernous fistulaB Lerut, C De Vuyst, J Ghekiere, et al.
Journal of Neurology|September 19, 2000
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosisL Vanopdenbosch, B Dubois, M B D'Hooghe, et al.
Acta Neurologica Belgica|November 25, 2024
Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with chronic lymphocytic leukemia (CLL) treated with Acalabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor: a case reportL Janssens, S Huybrecht, S De Blauwe, et al.
Acta Neurologica Belgica|December 1, 2017
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensusBen Sprangers, D Decoo, D Dive, et al.
Acta Neurologica Belgica|April 10, 2017
Corticosteroids in the management of acute multiple sclerosis exacerbationsI Smets, L Van Deun, C Bohyn, et al.
Multiple Sclerosis and Related Disorders|October 11, 2020
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosisH-P Hartung, T Berger, R A Bermel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2019
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter studyC E Leurs, Ham Twaalfhoven, B I Lissenberg-Witte, et al.
Pageof 1